NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health

NIH Study Examines the Efficacy and Safety of Glucosamine and Chondroitin in Promoting Knee Joint Health Initial findings from GAIT study indicate that "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis".
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Journal of Rheumatology Publishes Manuscript on Scientific Study of Celadrin™, a Natural-Based Product for Joint Function and Mobility Journal of Rheumatology Publishes Manuscript on Scientific Study of Celadrin™, a Natural-Based Product for Joint Function and Mobility New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA). New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA). New Research Shows Mineral Supplement SierraSil(TM) and Vincaria® Cat’s Claw Suppress Cartilage Degradation Findings are published in the current edition of the Journal of the American Nutraceutical Association (JANA). Christmas Tree Bark May Fight Arthritis Extract of scotch pine bark shows anti-inflammatory effect in preliminary study. Christmas Tree Bark May Fight Arthritis Extract of scotch pine bark shows anti-inflammatory effect in preliminary study. Christmas Tree Bark May Fight Arthritis Extract of scotch pine bark shows anti-inflammatory effect in preliminary study. Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain. Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain. Two Seminal Studies Demonstrate Benefit of Glucosamine And Chondroitin In Osteoarthritis Patients National Institutes of Health (NIH) trial shows effectiveness of glucosamine/chondroitin combination for moderate to severe pain, while multi-center European study favorably compares glucosamine to over-the-counter remedy for joint pain. Phytochemicals May Protect Cartilage, Prevent Pain in Joints Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme. Phytochemicals May Protect Cartilage, Prevent Pain in Joints Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme. Phytochemicals May Protect Cartilage, Prevent Pain in Joints Johns Hopkins researchers, in a study published in the Proceedings of the National Academy of Sciences, have determined that certain phytochemicals found in cruciferous plants, including broccoli, boost the activity of helpful phase 2 enzymes which in turn, help protect tisue and prevent inflammation. The cell study involved adding thse inducers to a dish containing chondrocyte cells that are crucial to maintaining healthy joints, with the inducers apparently preventing the activation of the inflammatory COX-2 enzyme. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. New Clinical Trial Demonstrates Effectiveness of SierraSil®, Nutraceutical Mineral Complex for Osteoarthritis Results of double-blind, randomized, placebo-controlled, multi-centered clinical trial, published in the Journal of Inflammation, indicate that SierraSil provided significant symptomatic relief after one week, to patients with osteoarthritis of the knee. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. NIH-Sponsored Trial Shows Supplements Relieve Arthritis Pain Council for Responsible Nutrition comments on recently released clinical trial results of glucosamine and chondroitin and pain relief from osteoarthritis. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Glucosamine Studied in Mouse Model of Multiple Sclerosis Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Study Shows Supplements Relieve Osteoarthritis Pain A clinical trial (Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)), sponsored by the National Institutes of Health (NIH), reported in the New England Journal of Medicine, has found that using a combination of the two supplements "significantly decreased" knee pain in osteoarthritis patients experiencing moderate-to- severe pain. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. Efficacy Of Glucosamine And Chondroitin Sulfate May Depend On Level Of Osteoarthritis Pain Study published in the New England Journal of Medicine shows that glucosamine plus chondroitin sulfate did not provide significant relief from osteoarthritis pain among all participants, but a a smaller subgroup of study participants with moderate-to-severe pain showed significant relief with the combined supplements. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. NEJM Study Shows Supplements Relieve Mild Forms of Arthritis NNFA comments on NIH GAIT study concluding that glucosamine and chondroitin are effective in helping people who suffer the most from osteoarthritis, those who experience moderate to extreme pain. New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain New Study To Evaluate Celadrin Capsules For Patients With Knee Pain Company announces that a new 60-day, double-blind, placebo-controlled multi-site study has been commissioned on Celadrin®, by its developer Imagenetix, Inc. on patients diagnosed with moderate to severe knee pain Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Research Breakthrough in Arthritis: Natural Product Activates Gene to Regenerate Human Cartilage Scientists at Case Western Reserve University and Albany Medical College have determined a natural product combination, Reparagen, has been shown to activate a critical repair gene, IGF-1, in human cartilage while blocking joint destruction associated with inflammation. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	SAN DIEGO, Nov 14, 2005 /PRNewswire via COMTEX/ -- Initial findings of the National Institutes of Health (NIH) Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) conclude, "combination glucosamine and chondroitin is effective in treating moderate to severe knee pain due to osteoarthritis (OA).(1)" The results from this groundbreaking multi-center trial were presented today in its entirety today at the Annual Scientific Meeting of the American College of Rheumatology (ACR) and give hope to the 35 million Americans who suffer from osteoarthritis. GAIT tested whether glucosamine and chondroitin used separately or in combination, and in comparison to placebo and celecoxib, are effective in reducing pain and improving functional ability in patients with knee osteoarthritis. Jason Theodosakis, M.D., a member of the steering committee for the $14 million NIH study, concludes: "The supplements glucosamine and chondroitin offer effective treatment to the millions of Americans who suffer from osteoarthritis. One very significant finding of GAIT is that the supplements actually outperformed the prescription drug for those with moderate to severe knee pain thus offering relief for those who need it most." (1) The Efficacy of Glucosamine and Chondroitin Sulfate in Patients with Painful Knee Osteoarthritis (OA): The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) Abstract, October 2005 Notes: for the study: Glucosamine and Chondroitin Sulfate were required to meet pharmaceutical standards as GAIT was conducted under an Investigational New Drug application. In the 301-400 mm WOMAC pain stratum, the response rate for Glucosamine + Chondroitin Sulfate (79.2%) was higher than Placebo (54.3%) (p=0.002)
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software